|Slideshows|April 3, 2017

Mortality Risk After Discharge From Psychiatric Care

Which patients are at greatest risk for premature death following discharge?

View the slides in PDF format.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Treating Patients With First-Episode Psychosis: Lessons From McLean OnTrack

ByMichael Murphy, MD, PhD,Allison Nelson-Eliot, LICSW

June 18th 2026

Assessment of Suicide Risk in Individuals With Schizophrenia

ByCarla Kotzé, PhD, MMed, MPhil, FCPsych,Johannes Lodewikus Roos, MD, DSc, MMed, FCPsych

June 17th 2026

Transcranial Direct Current Stimulation to Enhance Brain Activity: Applicability for Schizophrenia

ByTony Cunningham, PhD

June 17th 2026

Consensus on Overcoming Barriers to Long-Acting Injectable Use in Schizophrenia

ByLeighann Forbes, PhD

June 12th 2026

Podcast: Limitations of Current Diagnosis-Based Frameworks in Suicide Research. A Conversation With Jill Harkavy-Friedman, PhD, and Elizabeth Ballard, PhD

ByJenessa Johnston, PhD,Jill M. Harkavy-Friedman, PhD,Elizabeth Ballard, PhD

June 11th 2026

Latest CME

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

Register now!

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Mortality Risk After Discharge From Psychiatric Care

Related Content

Treating Patients With First-Episode Psychosis: Lessons From McLean OnTrack

Assessment of Suicide Risk in Individuals With Schizophrenia

Transcranial Direct Current Stimulation to Enhance Brain Activity: Applicability for Schizophrenia

Consensus on Overcoming Barriers to Long-Acting Injectable Use in Schizophrenia

Podcast: Limitations of Current Diagnosis-Based Frameworks in Suicide Research. A Conversation With Jill Harkavy-Friedman, PhD, and Elizabeth Ballard, PhD

Latest CME

Southern California Psychiatry Conference

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Trending on Psychiatric Times

Zolpidem: Restoring Sleep and Slowing Alzheimer Disease Progression

Sex Differences, Sleep Problems, and Psychological Well-Being in Older Adults

Treating Patients With First-Episode Psychosis: Lessons From McLean OnTrack

Transcranial Direct Current Stimulation to Enhance Brain Activity: Applicability for Schizophrenia

Sleep, Cognition, and the Bidirectional Brain, With Michael Scullin, PhD